CA2530672A1 - Method of detecting cancer - Google Patents
Method of detecting cancer Download PDFInfo
- Publication number
- CA2530672A1 CA2530672A1 CA002530672A CA2530672A CA2530672A1 CA 2530672 A1 CA2530672 A1 CA 2530672A1 CA 002530672 A CA002530672 A CA 002530672A CA 2530672 A CA2530672 A CA 2530672A CA 2530672 A1 CA2530672 A1 CA 2530672A1
- Authority
- CA
- Canada
- Prior art keywords
- cancer
- base sequence
- detecting cancer
- prognosis
- correlating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1288—Transferases for other substituted phosphate groups (2.7.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Cancer is detected by measuring the representation of .alpha.1,4-N-acetyl-D-glucosamine transferase gene in a body fluid sampled from a living body through detection of a region composed of an arbitrary continuous base sequence of 70 to 139 bp (base pairs) within the base sequence of SEQ ID NO. 1 and by correlating the measurement value with cancer presence or absence, development, progress degree or prognosis.
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-185696 | 2003-06-27 | ||
JP2003185696 | 2003-06-27 | ||
PCT/JP2004/009126 WO2005001089A1 (en) | 2003-06-27 | 2004-06-28 | Method of detecting cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2530672A1 true CA2530672A1 (en) | 2005-01-06 |
Family
ID=33549674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002530672A Abandoned CA2530672A1 (en) | 2003-06-27 | 2004-06-28 | Method of detecting cancer |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2005001089A1 (en) |
CA (1) | CA2530672A1 (en) |
WO (1) | WO2005001089A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1889920T3 (en) | 2005-04-13 | 2010-05-10 | Consejo Superior Investigacion | In vitro method atil identification of compound atil cancer therapy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3969469B2 (en) * | 1999-06-03 | 2007-09-05 | 生化学工業株式会社 | N-acetylglucosamine transferase and DNA encoding the same |
AU2002255478A1 (en) * | 2001-01-10 | 2002-09-12 | Pe Corporation (Ny) | Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof |
-
2004
- 2004-06-28 JP JP2005511073A patent/JPWO2005001089A1/en not_active Withdrawn
- 2004-06-28 WO PCT/JP2004/009126 patent/WO2005001089A1/en active Application Filing
- 2004-06-28 CA CA002530672A patent/CA2530672A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPWO2005001089A1 (en) | 2006-11-02 |
WO2005001089A1 (en) | 2005-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004013357A3 (en) | Nucleotide sequences specific to francisella tularensis and methods for the detection of francisella tularensis | |
DE60035174D1 (en) | INVASIVE METHOD FOR IN VIVO ANALYTIC MEASUREMENT | |
PT1812590E (en) | Methods and reagents for the detection of melanoma | |
EP1179317A3 (en) | Heart-sound analyzing apparatus | |
WO2004093644A3 (en) | Methods and apparatus for genetic evaluation | |
EP2272988A3 (en) | Method for detecting human papillomavirus mRNA | |
WO2004030511A3 (en) | Prostate cancer biomarkers | |
HUP0301031A2 (en) | Degradable nucleic acid probes and nucleic acid detection methods | |
EP1611837A3 (en) | Fluid handling devices | |
PT1633888E (en) | Means and method for the detection of target nucleotide sequences using ligation assays with improved oligonucleotide probe pairs | |
HUP0303888A2 (en) | Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
WO2003020878A3 (en) | Amplification and detection reagents for hiv-1 | |
NZ588618A (en) | Mal, a molecular diagnostic marker for hpv-induced invasive cancers and their high-grade precursor lesions | |
CA2510377A1 (en) | Use of nicotinamide n-methyltransferase as a marker for colorectal cancer | |
EP1077365A3 (en) | Ultrasonic-wave propagation-time measuring method, gas-pressure measuring method, gas-flow rate measuring method, and gas sensor | |
DE60330324D1 (en) | SELF-CENTERING DETECTION DEVICE | |
CA2530672A1 (en) | Method of detecting cancer | |
AU7027600A (en) | Sensor probe | |
WO2007092279A3 (en) | Detection of contaminating dna via amplification of sequences of less than 100 bp | |
WO2004011908A3 (en) | Methods for detecting nucleic acid sequence variations | |
WO2004081519A3 (en) | Method and apparatus for detecting a gas | |
WO2002103059A3 (en) | Innate immunity markers for rapid diagnosis of infectious diseases | |
WO2001083816A3 (en) | Method for detecting tumors | |
WO2002083899A1 (en) | Cancer-associated genes | |
HUP0303890A2 (en) | Expression amalysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |